ChemChina seeks blockbuster $20bn European tranche
ChemChina is raising $20bn of loans in Europe for its $43bn acquisition of Syngenta although many bankers had expected the firm to raise just $13bn outside China.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts